“I am astonished that they think this (clinical trials) is a great plan for getting access, and we’re going to make it abundantly clear that it’s unethical to direct patients to try to get their access through a clinical trial. Shame on the government.”
Lead Counsel on the Charter Challenge for medical psilocybin, Paul Lewin, recently sat down with CEO Spencer Hawkswell to discuss the path to medical psilocybin regulations, and how the current framework for accessing psilocybin is extremely flawed.
Paul has led many successful Charter challenges and tells us that there are high hopes for a victory if we can fundraise enough to support the patients & healthcare practitioner who are suing the federal government.
